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Abstract.  Adult rat hepatocytes cultured on type IV 
collagen,  fibronectin, or laminin and maintained  in 
serum-free medium were examined by indirect immu- 
nofluorescence using polyclonal antibodies against ex- 
tracellular matrix proteins.  An extensive fibrillar ma- 
trix containing fibronectin and fibrin was detected in 
all hepatocyte cultures irrespective of the exogenous 
matrix  substratum used to support cell adhesion.  Fi- 
brils radiated from the cell periphery and covered the 
entire culture substratum.  In addition,  thicker fibers or 
bundles of fibers were localized on top of hepatocytes. 
This matrix did not contain laminin or the major types 
of collagen found in the liver biomatrix (types I, III, 
and IV).  Isolation of the fibrillar matrix and analysis 
on polyacrylamide gels under reducing conditions 
demonstrated a major 58-kD polypeptide, derived from 
I~-fibrinogen as indicated by immunoblotting and two- 
dimensional peptide mapping.  Plasmin rapidly dis- 
solved the matrix.  Deposition of the fibrin matrix  in 
hepatocyte cultures was arrested by hirudin,  by spe- 
cific heparin oligosaccharides that potentiate thrombin 
inhibition by antithrombin III, and by dermatan  sul- 
fate, an activator of heparin cofactor H-mediated inhi- 
bition of thrombin.  The results indicate that hepato- 
cytes in culture synthesize and activate coagulation 
zymogens. In the absence of inhibitory and fibrinolytic 
mechanisms,  a fibrin clot is formed by the action of 
thrombin on fibrinogen.  Fibronectin attaches to this 
fibrin clot but fails to elaborate a fibrillar matrix on its 
own in the presence of coagulation inhibitors. 
T 
HE relation  between the hepatic  extracellular  matrix 
(17, 28, 38) and normal functions  of the liver paren- 
chyma is  evident from pathological  conditions  that 
manifest abnormal and disorderly matrix  accumulation  (17, 
39, 40). Isolated hepatocytes  can be maintained  in vitro on 
a variety of biomatrix protein substrata,  offering an excellent 
system to study cell-matrix interactions.  We have recently 
used fibronectin,  type IV collagen,  and laminin substrata to 
support serum-free growth  of rat hepatocytes  and have re- 
ported  on  substratum-specific  morphological  (6,  30)  and 
functional  (42) effects. 
In  this  report,  immunofluorescence  microscopy  and  a 
variety  of polyclonal antibodies were used to study the ar- 
chitecture of the extracellular  matrix produced by primary 
hepatocyte cultures  grown on type IV collagen,  laminin,  or 
fibronectin substrata. Our major finding is that rat liver hepa- 
tocytes synthesize an extensive fibrillar  matrix  in vitro con- 
sisting of polymerized fibrin and fibronectin.  The matrix did 
not contain  any  collagenous  components and was equally 
prominent in all hepatocyte cultures,  irrespective of the sub- 
stratum used to support cell adhesion.  Formation of the ma- 
trix was inhibited  by anti-clotting  agents  such as heparin, 
hirudin,  and dermatan sulfate. 
Materials and Methods 
Cells 
Hepatocytes were isolated from young adult female Sprague-Dawley rats by 
liver perfusion (5) and cultured in a basal arginine-free DME (45)  sup- 
plemented with ornithine (0.5  mM),  insulin  (0.1 ~,1),  dexamethasone 
(0.025 ~tM), penicillin (60 I.tg/mi), streptomycin (100 ~tg/ml), and gentamy- 
cin (50 ~tg/ml). Cells were plated onto plastic petri dishes or glass coverslips 
coated with type IV collagen (40 ~tg/ml), fibronectin (30 lxg/ml), or laminin 
(40 I~g/ml) for 1 h at 37~  When glass substrata were used, the matrix pro- 
teins were either passively absorbed or covalently linked to the glass (2) 
with no apparent difference regarding the effect on the cell culture. Serum- 
free medium was used throughout when matrix protein substrata were used. 
Hepatocytes were also plated onto plain glass or plastic substrata in medium 
supplemented with 20%  FCS. 2 h after inoculation the medium was dis- 
carded and the culture was thereafter maintained in serum-free medium. 
Proteins and Glycosaminoglycans 
Fibronectin was isolated from rat plasma on a gelatin-Sepharose column 
(14).  Type IV collagen and laminin were isolated from the Engelbreth- 
Holm-Swarm sarcoma implanted in lathyritic mice as described (20). Rat 
fibrinogen, antithrombin HI, plasmin, heparin, dermatan sulfate, hirudin, 
and bacterial collagenase (Sigma type IV) were purchased from the Sigma 
Chemical Co. (St. Louis, MO). Heparin fragments with high or low affinity 
for antithrombin RI were prepared by partial deamination of heparin with 
nitrous acid, fractionation on antithrombin III-Sepharose, and gel filtration 
(24, 48). 
￿9  The Rockefeller  University  Press, 0021-9525/87/11/2417/9  $2.00 
The Journal  of Cell Biology,  Volume 105, November 1987 2417-2425  2417 Antibodies 
Rat plasma fibronectin antibodies were raised in rabbits in this laboratory. 
Type IV collagen and laminin antisera were raised in rabbits by Dr. D. M. 
Bissell (San Francisco General Hospital, San Francisco, CA). Sheep anti- 
rabbit fibrinogen was a gift from Dr. P. Gaffney (National Institute of Bio- 
logical Standards and Control, London, England) and goat anti-rat fibrino- 
gen was purchased from Sigma Chemical Co. Antibodies against collagen 
type I and HI were kindly provided by Drs. M. Pope and A. Temple (Clini- 
cal Research Centre, Northwick Park,  London).  Fluorophore-conjugeted 
antibodies used were the following: goat anti-rabbit IgG/rhodamine (Cap- 
pel Laboratories, Inc., Cochmnville, PA), goat anti-rahbit/fluorescein iso- 
thiocyanate  (Miles-Yeda,  Rehovot,  Israel),  rabbit  anti-sheep/fluorescein 
(Dr. M. Parkhouse, National Institute for Medical Research, London), don- 
key anti-sheep IgG/flnorescein, horseradish peroxidase-conjugated anti- 
rabbit IgG and anti-goat IgG (Sigma Chemical Co.). 
Indirect Immunofluorescence 
HeI~tocyte cultures on 13-mm-diam coverslips were fixed in freshly made 
paraformaldehyde for 20 rain at room temperature. After extensive washing 
they were incubated with antiserum for I h at room temperature, thoroughly 
rinsed, and incubated with the appropriate fluorophore-conjuguted second 
antiserum for 1 h at room temperature. Both antibodies were diluted 1:40 
in PBS. The coverslips were exhaustively rinsed in PBS and mounted on 
microscope  slides  in  glycerol/PBS  (9:1)  containing  phenylene diamine 
(1 mg/ml).  In double-labeling experiments,  sheep anti-rabbit fibrinogen 
was used together with rabbit anti-rat fibronectin (1:40 and 1:100 final dilu- 
tions,  respectively),  followed by rhodamine-conjngated F(atf)2 fragment 
goat anti-rabbit IgG and fluorescein-conjngated donkey  anti-sheep IgG 
(1:40 final dilutions). The fluorescein-conjugeted donkey anti-sheep IgG 
(batch No. 44F-8813; Sigma Chemical Co.) showed some reactivity with 
rabbit immunoglobulins. Therefore, in order to avoid nonspecific interac- 
tions with the rabbit anti-rat fibronectin antibody, the flnorescein-conju- 
gated antibody was pretreated with nonimmune rabbit serum for 15 rain at 
room  temperature and then incubated with protein A-Sepharose 413 for 
30 rain at room temperature. The supernatant was removed and used in the 
double-labeling experiments. This treatment did not affect the reactivity of 
the antibody with sheep IgG indicating that in comparison with rabbit IgG, 
donkey IgG has a reduced afliulty for protein A.  Matrix immunostaining 
with anti-fibrinogen was achieved in both double-label (using sheep anti- 
rabbit fibrinogen) and in single-label (using goat anti-rat fibrinogen) experi- 
ments. Both fibdnogen antibodies reacted with reference standard fibrino- 
gen in immunoblots. 
Controls in immunofluorescence experiments included omission of the 
first or second antibodies, use of preimmtme sera, and absorption of the 
fibronectin or fibrinogen antibody with the respective antigen. All controls 
were negative. The slides were examined in a Zeiss ICM 405 inverted mi- 
croscope equipped for epifluorescence. 
Matrix Isolation 
The hepatocyte matrix was isolated from hepatocytes grown for 40 h  on 
plastic petri dishes. The culture was rinsed and, using a drawn-out Pasteur 
pipette, long bundles of fibrils attached to dorsal cell surfaces were removed 
and solubilized in Laemmli's electrophoresis sample buffer (23). The whole 
procedure was monitored with an inverted microscope. Some cells were in- 
evitably dislodged and removed together with the matrix hut their mass was 
small in relation to that of the matrix. 
Metabolic Labeling 
Labeling of hepatocyte cultures with [35S]methionine was performed as de- 
scribed earlier (42). Briefly, cells were labeled for 20 h with 25 gCi/ml of 
[35S]methionine in basal medium containing  1%  of the usual amount of 
methionine. 
PAGE 
Electrophoresis of protein samples was performed in 5-12% gels using the 
buffer system of Laemmli (23). Running buffers contained SDS and samples 
were reduced with [3-mercaptoethanol. 
Immunoblotting 
This was based on established methods (8, 9). Protein samples on reduced 
SDS-PAGE were transferred to nitrocellulose membrane filters (Schleicher 
&  Schull, Dassel,  FRG) in a Transblot apparatus (Bio-Rad Laboratories, 
Richmond, CA). The transfer was done overnight at 30 V in 25 mM Tris 
pH 8.3 containing glycine (192 mM), SDS (0.1%), and methanol (20%). The 
nitrocellulose sheet was stained with Poncean S protein stain (BDH Chemi- 
cals  Ltd.,  Poole,  England)  and  a  photographic  record  was  kept.  The 
nitrocellulose was then washed in 50 mM Tris, 150 mM NaCI, 0.1% NP-40 
pH 7.5 (wash buffer) containing 5% BSA for 1 h, soled in a plastic bag 
with 10 ml of the same buffer containing 150 gl of antibody, and incubated 
for 1 h at room temperature with rocking. After incubation the nitrocellu- 
lose was thoroughly washed and sealed in a new plastic bag with 10 ml of 
wash buffer plus 5 % BSA containing the appropriate second antibody con- 
jugated with horseradish peroxidase (1:1,000 dilution). It was shaken for 1 h 
at room temperature, thoroughly rinsed, and immersed in 50 mM sodium 
acetate pH 5.0. Chromogenic substrate (3-amino-9-ethyl carbazole in DMSO) 
was added to a final concentration of 200 ~tg/ml and hydrogen peroxide was 
added to 0.01%.  After color development the blots were washed in distilled 
water and dried. 
Peptide Mapping 
This was carried out as described (13). In outline, protein bands in acryl- 
amide gels were iodinated, digested with trypsin, and the resulting peptides 
were first subjected to electrophoresis and then chromatographed (at fight 
angles) on cellulose paper (Eastman Chromogram).  The plates were ana- 
lyzed by autoradiography on Fuji x-ray film using intensifying screens. A 
number of control experiments were performed to eliminate the possibility 
that contaminating proteins (31, 46) affected the results; maps were done of 
unrelated proteins such as albumin and acfin (run on adjacent tracks of the 
same gels) and of blank pieces of gels. 
Inhibition Experiments 
The effect of various coagulation inhibitors on the formation of the hepato- 
cyte extracellular matrix was studied using sparse cell cultures grown on 
13-mm-diam glass coverslips. Cells were inoculated at equal density and left 
to attach and spread for 2 h. The coverslips were then transferred to four- 
well culture plates and covered with 500 B1 of medium containing the appro- 
priate inhibitors.  Elaboration of an extracellular fibrillar matrix was as- 
sessed 20 h  after inoculation by indirect immunofluorescent staining of 
fibmnectin and fibrinogen. 
Results 
Hepatocytes Synthesize an Extracellular Matrix 
Containing Fibronectin and Fibrinogen 
Adult rat hepatocytes seeded on various substrata (see Mate- 
rials and Methods) and maintained in serum-free medium in 
the presence of insulin and dexamethasone were processed 
for immunofluorescence ,o30 h after inoculation. Fibronec- 
tin immunofluorescent staining could be detected on the sur- 
face of parenchymal cells ,02 h after inoculation (Fig.  1, a 
and b; 2- and 3-h hepatocyte cultures, respectively). In lon- 
ger-term cultures (25 h onwards) the antiserum stained an ex- 
tensive fibrillar network (Fig. 1, d, f, h-j). Individual fibrils 
could often be visualized with phase contrast microscopy 
(Fig. 1 c; Fig. 1 d is corresponding anti-fibronectin fluores- 
cent image). Overall three distinct classes of filaments could 
be distinguished depending on location and/or size. Fibers, 
or bundles of fibers often being several millimeters long, 
could be localized on top of hepatocytes, presumably an- 
chored on dorsal cell surfaces (Fig.  1,  c and d).  Thinner 
fibers were seen on the substratum, radially emanating from 
the cell periphery (Fig. 1, fand h) and the entire substratum 
area was covered with a fine fibrillar network (Fig.  1, f  and 
h).  In addition to these thin fibers,  short,  thin fibrils im- 
munoreactive with  flbronectin could occasionally  be  de- 
tected in the cell-substratum space (Fig. 1 i). Overall we did 
not notice any difference in the fibronectin-containing matrix 
depending on the type of substratum used to support cell at- 
tachment. 
The Journal of Cell Biology, Volume 105,  1987  2418 Figure 1.  Hepatocytes grown either on a type IV collagen substratum in serum-free medium for 30 h (a-i) or cultured in the presence 
of serum for 2 h and thereafter maintained in serum-free medium for 30 h  (j). (a) Fibronectin immunofluorescent staining of cultured 
hepatocytes, 2 h after inoculation. Fibronectin is just detectable on the cell surface. (b) Fibronectin immunofluorescence in a 3-h hepatocyte 
culture. Note increased fluorescence in comparison to cells in a. (c) Phase contrast image of hepatocyte culture showing extracellular matrix 
fibrils. The plane of focus is on dorsal cell surfaces. (d) Same field, fibronectin immunofluorescent staining of the extracellular matrix. 
(e) Same field, fibrinogen immunofluorescent staining. Note coincidence with fibronectin immunostaining in d and phase contrast image 
in c. (f) Fibronectin immunofluorescent staining on culture substratum. The plane of focus is on the substratum. Note pericellular  filaments 
delineating cell periphery and finer filaments covering the substratum. (g) As in  f, fibrinogen immunostaining. (h) Higher resolution image 
of fibronectin-immunoreactive fibrils on  substratum intercellular spaces.  (i) Hepatocytes stained with anti-fibronectin. The  antibody 
penetrated the cell-substratum space and stained a  fibrillar matrix. These fibrils could not be detected with anti-fibrinogen. (j) Matrix 
treated with collagenase and stained with anti-fibronectin; no degradation is seen. Bars, 20 ~tm. 
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laminin, which are major components of the liver biomatrix 
(17, 28, 38), we used the relevant antisera in immunofluores- 
cence  experiments.  Type  IV  collagen  and  laminin  were 
localized in the cellular mass with no extracellular matrix 
staining being evident. The matrix did not contain any colla- 
gens type I or III either (results not shown). Lack of filamen- 
tous matrix staining with collagen antisera was observed 
using both formaldehyde-fixed  and live cells. To confirm the 
absence  of collagen,  hepatocytes were  seeded  in  serum- 
containing medium and after a  2-h incubation were main- 
rained in serum-free medium for 30 h. The culture was then 
treated  with perfusion-grade collagenase (0.5  mg/mi) for 
30 min and upon staining with anti-fibronectin the matrix 
appeared  indistinguishable  from  that  in  control  cultures 
(Fig.  1 j). 
Since  liver parenchymal cells are  known to  synthesize 
fibrinogen and other components of the coagulation cascade 
(11) we tested the possibility that the matrix contains fibrino- 
gen. In double-labeling experiments using fibronectin and 
fibrinogen antisera, fibrinogen colocalized with fibronectin 
along the fibrils of the extracellular matrix (Fig.  1, d and e, 
andfand g). This was evident on both the dorsal cell surface 
(Fig. 1, d and e) and the substrauun-attached fibrils (Fig. 1, 
f  and g).  It was only the  subeellular fibronectin-positive 
structures (Fig.  1 i) that showed virtually no immunoreac- 
tivity with the fibrinogen antibody (result not shown). The 
hepatocytes themselves also stained with anti-fibrinogen, but 
it was of interest that in occasional cell preparations contain- 
ing a few nonparenchymal cells, in addition to hepatocytes, 
stellate cells (presumably Kupffer cells) were strongly im- 
munoreactive with the fibrinogen antibodies. Anti-fibronec- 
tin did not react with these cells (results not shown). 
In a previous study (25) a fibrillar, fibroneetin-containing 
matrix was described and attributed to the presence of dexa- 
methasone in the culture medium. However,  in our studies 
we did not notice any major difference in the ability of hepa- 
tocytes to elaborate either the cell surface, or the substrate- 
bound matrix when the medium was depleted of dexametha- 
sone and insulin (results not shown). 
To demonstrate further that fibrinogen provides the essen- 
tial component of  the hepatocyte  matrix, we resorted to isola- 
tion and characterization of the hepatocyte matrix and to 
coagulation inhibitors. 
Isolation and Characterization  of the Hepatocyte 
ExtraceUular Matrix 
Attempts to isolate the matrix using chemical means such as 
ionic or nonionic detergents and denaturing agents such as 
urea or guanidine, alone or in combination, failed to yield 
an intact and cell-free preparation. However, it was feasible 
to physically dislodge bundles of  fibers attached at their ends 
to  dorsal  cell  surfaces  (see  Materials and  Methods)  and 
analyze these by SDS-PAGE,  immunoblotting, and peptide 
mapping. 
The main protein of the matrix had a relative molecular 
mass of 58K as shown by reduced SDS-PAGE  and either 
staining with Coomassie Blue (Fig. 2 a) or by radioautogra- 
phy of metabolically radiolabeled (Fig. 2 b) matrix proteins. 
A number of other bands were also visible, the most promi- 
nent of which was of 55 kD. The 58/55-kD bands reacted in 
immunoblotting with anti-fibrinogen, as expected for fibrin 
Figure 2. Analysis of the hepatocyte  matrix by SDS-PAGE and im- 
munoblotting. (a) Coomassie Blue-stained matrix proteins in re- 
duced SDS-PAGE. (b) Fluomgraphy of reduced matrix proteins, 
metabolically labeled with  [35S]methionine. (c)  Matrix proteins 
transferred on nitrocellulose membrane and overlayed with anti- 
fibrinogen. (d) As in c, overlayed with anti-fibronectin. 
(Fig. 2 c). Using anti-fibronectin the characteristic doublet 
at 220 kD was distinguished (Fig. 2 d). 
The relation between the 58-kD band and the t-monomer 
of fibrinogen was unequivocally established by tryptic pep- 
tide maps of the matrix component and of the subunits of ref- 
erence standard rat fibrinogen (Fig. 3). The 58-kD band of 
the hepatocyte matrix (Fig.  3,  m~) gave a  similar peptide 
pattern after trypsin digestion, electrophoresis, and chroma- 
tography to that of the B-chain monomer of fibrinogen (Fig. 
3,  b  and e, respectively). The 55-kD peptide (Fig.  3, m2) 
could be a degradation product of the 58 kD protein (Fig. 3 
c). On the basis of  published results (29), the band of 105 kD 
(Fig. 2, a and b) could be 7-chain dimers; this band is weakly 
immunoreactive  with anti-fibrinogen (Fig. 2 c). ~t-chain poly- 
mers (Mr > 400,000;  reference 29) were not seen, possibly 
due to their low  solubility in  the electrophoresis  sample 
buffer and hence exclusion from the gel. 
Inhibition of  Matrix Formation and l~brinolysis 
Inhibition of matrix formation was drastic with heparin and 
antithrombin III. Hepatocyte cultures seeded on type IV col- 
lagen were maintained in serum-free medium in the presence 
of antithrombin III (1 U/ml) and heparin (5 ~tg/ml) for 30 h 
and then examined for fibronectin and fibrinogen immuno- 
reactivity. The results are shown in Fig. 4, a (fibronectin im- 
munostaining) and b  (same field, fibrinogen immunostain- 
ing).  No  fibrillar matrix was  found either on  the dorsal 
hepatocyte surfaces or attached to the substratum. Instead, 
The Journal  of Cell Biology,  Volume 105, 1987  2420 Figure 3. Tryptic peptide maps of  the major proteins in the hepatocyte extracellular matrix and of standard fibrinogen chains. (a) Hepatocyte 
matrix (lane I) run alongside rat fibrinogen (lane H) in SDS-PAGE. The positions of the t1-, 1~-, and y-fibrinogen chains and of the major 
matrix proteins are indicated. These bands were cut off, iodinated, and trypsinized, and the resulting peptides were subjected to electropho- 
resis and then chromatographed at right angles. (b) Peptide map of the 58-kD matrix protein. Arrows indicate direction of electrophoresis 
(E) and chromatography (C). (c) Peptide map of the 55-kD peptide. (d) Peptide map of the a-fibrinogen chain. (e) Peptide map of the 
13-fibrinogen chain.  (f) Peptide map of the y-fibrinogen chain. 
a punctate pericellular fluorescence was observed when the 
fibronectin antiserum was used (Fig. 4 a). These fibronectin- 
positive sites were mostly devoid of fibrinogen (Fig. 4  b). 
Fibronectin failed to elaborate a matrix on its own. This inhi- 
bition took place in the presence of heparin (0.5-5  Ixg/ml) 
alone whereas antithrombin (1 U/ml) in the absence of hepa- 
rin had a markedly reduced effect (not shown). 
The  inhibitory action  of heparin  was  analyzed  further 
using heparin oligosaccharide fragments of different chain 
lengths and with high or low affinity for antithrombin III (24, 
48).  Dermatan sulfate and hirudin were also used.  High- 
affinity heparin molecules with 18 or more monosaccharides 
potentiate inactivation of thrombin by antithrombin III (24). 
Hirudin (26, 27) and dermatan sulfate (33,  35, 49) can also 
inhibit thrombin. Dermatan sulfate exerts its inhibitory ac- 
tion by activating heparin cofactor II which, in turn, inacti- 
vates thrombin (33, 49). The effects of  these inhibitors on the 
formation of the hepatocyte matrix are summarized in Table 
I.  High-affinity octadecasaccharide  (and  bigger)  heparin 
molecules inhibited the formation of the matrix at very low 
Stamatoglou et al. Fibrin  Clotting in Hepatocyte  Cultures  2421 Figure 4. Immunofluorescent staining of hepatocytes maintained in culture for 30 h.  (a) Fibronectin  staining of bepatocytes on type IV 
collagen maintained in serum-free medium in the presence of antithrombin III and heparin. No matrix was formed. (b) Same field, fibrino- 
gen staining. (c) Fibronectin staining of hepatocytes maintained in serum-containing medium. Surface fibrils are reduced in number.  (d) 
Control  experiment:  hepatocytes  were inoculated in the presence  of serum for 2 h and thereafter  maintained  in serum-free  medium. 
Fibronectin  immunostaining.  Bars,  20 tam. 
concentrations  (50-100  ng/ml),  whereas  heparin oligosac- 
charides with low affinity for antithrombin III were not effec- 
tive inhibitors.  Furthermore, tetradecasaccharides or smaller 
high-affinity fragments failed to inhibit fibrin deposition at 
concentrations up to 1 lag/ml.  Hirudin and dermatan sulfate 
inhibited  formation of the matrix (Table I). 
Another  anticoagulant  tested  was  warfarin,  a  drug  ad- 
ministered  to patients  with  thrombotic diathesis,  which  is 
purported to inhibit enzymes that catalyze the reduction of 
vitamin K to its active hydroquinone form (15, 43).  Vitamin 
K functions as a cofactor for vitamin K-dependent carboxy- 
lase which activates coagulation zymogens (43,  44).  When 
hepatocytes were maintained in serum-free medium contain- 
ing warfarin (50-500 I.tM) the amount of matrix associated 
with dorsal cell surfaces was reduced, but no change could 
be observed in the substratum-bound matrix. Visually, the 
effect  was  similar  to  that  of maintaining  the  cultures  in 
serum-containing medium (see below). 
Addition of plasmin (0.3  U/ml), the main enzyme in the 
fibrinolytic pathway, in 40-h hepatocyte cultures, resulted in 
rapid degradation of the matrix and in cell rounding. In sepa- 
rate experiments we found that glass-adsorbed fibrinogen did 
not support hepatocyte adhesion in the presence of 20 laM 
cycloheximide that was added to prevent synthesis and secre- 
tion of fibronectin and other spreading factors. Since plasmin 
treatment finally detached cells, presumably some proteoly- 
sis of adhesive factors such as fibronectin occurred in addi- 
tion to fibrin degradation. 
Effect of  Serum 
When hepatocytes were seeded in the presence of serum and 
the culture medium was replaced 2 h after inoculation with 
serum-free medium, the appearance of the matrix was indis- 
tinguishable after 25-52 h in culture from that of cells seeded 
on type IV collagen, fibronectin,  or laminin in serum-free 
medium. However, we noticed that if hepatocytes were main- 
mined in serum-containing medium, the amount of fibrillar 
matrix was significantly decreased. Fig. 4, c and d illustrate 
hepatocyte cultures that were inoculated in the presence of 
serum. After a 2-h incubation cells were maintained either 
in serum-containing (Fig.  4  c) or in serum-free (Fig.  4  d) 
medium for 25 h.  Fibronectin immunostaining showed that 
inclusion of serum resulted in reduced matrix accumulation 
on dorsal cell surfaces (Fig. 4, c and d). No effect on the sub- 
strate matrix could, however, be distinguished.  Also a cer- 
tain variation of this serum inhibition on matrix accumula- 
tion was observed among different serum batches. 
Discussion 
We have shown that hepatocytes in serum-free primary cul- 
ture synthesize a fibronectin-containing fibrin clot. Although 
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Cultures by Glycosaminoglycans and Hirudin 
Inhibition 
Inhibited  of matrix 
Inhibitor  protease  Concentration  formationfl 
glycosamino- 
glycans/ltg/ml 
hirudin/U/ml 
Heparin HA 40-50**  Thrombin  0.05-2  + 
Heparin LA 40-50*  0.05-2  - 
Heparin HA  18-24"*  Thrombin  0.05 
0.1-2  + 
Heparin LA  18-24"  0.05-1  - 
2  + 
Heparin HA  10-14"*  Factor Xa  0.05-1 
2  + 
Heparin LA  10-14"  0.05-2  - 
Dermatan sulfatew  Thrombin  1 
10  + 
20  + 
Hirudin  Thrombin  2--40  + 
Inhibitors  were  added  in  freshly  seeded  hepatocyte  cultures  maintained  in 
serum-free medium (see Materials and Methods). The cultures were immuno- 
stained for fibroneetin and fibrinogen 20 h after inoculation and the presence 
or absence of extracellular  matrix was noted. 
* Heparin oligosaccharides isolated by partial nitrous acid cleavage of heparin, 
affinity chromatography on antithrombin III-Sepharose, and gel filtration. HA 
and LA, high and low affinity for antithrombin HI, respectively. Numerals indi- 
cate number of monosaccharide  residues  in the saccharide  sequences. 
* Activates antithrombin 111. 
w  Activates heparin cofaetor II. 
II Inhibition of matrix formation is indicated by +, whereas  -  signifies pres- 
ence of fibrillar matrix at equal density to that in control cultures. 
fibrillar extracellular structures in hepatocyte cultures have 
been described in earlier studies using scanning electron mi- 
croscopy (52)  and fibronectin immunofluorescent staining 
(25, 50), results on the molecular composition of the matrix 
have not, to our knowledge, been published before. In one 
of these studies (25) the formation of this matrix was thought 
to be  induced by the synthetic glucocorticoid dexametha- 
sone.  Our  observations  find this  claim unwarranted.  We 
stress,  however,  the  limitation of immunofluorescence in 
conclusively establishing quantitative differences. Hepato- 
cytes are known to secrete fibrinogen and fibronectin (11, 34, 
42, 45, 50) and this secretion is known to increase upon addi- 
tion of dexamethasone (1,  37),  as is the secretion of other 
acute phase reactants (3, 4, 34). 
The type of exogenous matrix substratum used did not 
seem to affect the formation of the fibrin-fibronectin matrix 
and elaboration of this matrix was neither necessary nor 
sufficient for initial cell attachment and spreading since these 
phenomena proceeded in the absence of  protein synthesis but 
required the presence of an exogenous matrix substratum for 
initiation (6).  Fibrinogen itself did not support hepatocyte 
adhesion, but fibronectin fibrils were found on the underside 
of spread cells suggesting an involvement of endogenous ma- 
trix-associated fibronectin in cell adhesion of established 
cultures. This requirement for fibronectin in cell adhesion to 
fibrinogen and fibrin was demonstrated in earlier studies 
(16), although recently fibronectin was shown to be required 
for migration of cells (fibroblasts)  into plasma clots but not 
for cell adhesion and spreading (21). 
Polymerized fibrin is generated in vivo by the action of the 
serine protease thrombin on soluble fibrinogen (for reviews 
on blood coagulation see references 12, 18). Thrombin is the 
final product in a cascade of zymogen activations into serine 
proteases; each activated protease catalyzes the next reaction 
of the series. Most of the proteins in the coagulation cascade 
are made in the liver parenchyma (11, 54, 55) and our results 
showing the formation of a fibrin clot in isolated hepatocyte 
cultures emphasize the role of the hepatocyte in coagula- 
tion. Nonparenchymal cells were scarcely observed in our 
cultures and the matrix was seen to be closely associated 
with the hepatocyte surface. 
At this stage we cannot define the factor(s) involved in the 
initiation of the clotting mechanism in hepatocyte cultures. 
The hepatocyte apparently produces proteins required for 
blood coagulation according to the intrinsic as well as the ex- 
trinsic pathway of activation (11, 54, 55).  However,  throm- 
boplastin,  the  specific trigger component of the extrinsic 
pathway, was not detected in significant amounts in our cell 
cultures (assay performed by Dr. Hans Prydz, University of 
Oslo, Norway). In our system, formation of the fibrin net- 
work was prevented by agents that inactivate, or promote the 
inactivation of,  thrombin.  Heparin oligosaccharides with 
high affinity for antithrombin III thus accelerate the inhibi- 
tory effect of antithrombin 11/on this protease (7), provided 
that the saccharide chain equals or exceeds 18 monosaceharide 
units; shorter fragments selectively promote the inactivation 
of factor Xa (24). Moreover, thrombin is inhibited by heparin 
cofactor II, and this reaction is stimulated not only by hepa- 
rin (with high or low affinity for antithrombin III) but also 
by  dermatan  sulfate,  another  sulfated glycosaminoglycan 
with anticoagulant properties (32, 33, 35, 49). Finally, throm- 
bin is directly and specifically inactivated by hirudin (26, 
27). The inhibitory effects of the various saccharides, and of 
hirudin,  on  the  generation  of fibrin  by  the  hepatocytes 
strongly suggest that this process occurs by specific cleavage 
of fibrinogen by thrombin. The significant, albeit weaker, 
effect of smaller heparin oligosaccharides with high affinity 
for antithrombin is also compatible with the involvement of 
factor Xa.  The two reactions catalyzed by factor Xa and 
thrombin conclude the coagulation process (and are common 
to the extrinsic and intrinsic pathways).  These conclusions 
imply that both antithrombin III and heparin cofactor II are 
synthesized by the liver parenchyma cells,  in accordance 
with results of other studies (22). 
An important deduction from our observations is that the 
hepatocyte heparan sulfate (19, 36) is either incapable of, or 
insufficient in quantity to exert inhibition of clotting. This 
may appear to contradict reports on the anticoagulant prop- 
erties of heparan sulfates from liver (49) and inhibition ex- 
periments  with purified rat liver  heparan  sulfate will  be 
needed to clarify the issue. Heparan sulfates from other tis- 
sues, especially endothelium, are known inhibitors of coagu- 
lation (33, 41, 47). 
Significant fibrinolysis did not appear to take place in he- 
patocyte cultures,  as expected,  since hepatocytes produce 
plasminogen activator but not plasminogen (53), the inactive 
precursor of plasmin. The partial inhibition of matrix ac- 
cumulation in cultures maintained in serum could be due to 
the presence of plasminogen in the serum. An alternative 
possibility  is  that  antithrombin  is  present  in  serum  in 
sufficient  concentration to inhibit fibrin formation even in the 
absence of added polysaccharide. The incomplete inhibition 
Stamatoglou et al. Fibrin Clotting in Hepatocyte Cultures  2423 by warfarin is possibly due to the existence of an alternative 
pathway for vitamin K reduction which is not affected by cou- 
marin drugs (51). 
The liver is of fundamental importance in hemostasis and 
impaired function could precipitate severe abnormalities in 
coagulation, such as hemorrhage or disseminated intravas- 
cular coagulation (10, 11). The hepatocyte in culture may offer 
a simple system to study the regulation of coagulation and 
to assess the use of factors such as activators or inhibitors to 
modulate clotting. 
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